Radiotherapy-induced hypopituitarism: a review

References

• Oeffinger KC, Mertens AC, Sklar CA et al. Chronic health conditions in adult survivors of childhood cancer. N. Engl. J. Med.355(15), 1572–1582 (2006).
   PubMed Web of Science ®Google Scholar
• Oeffinger KC, Tonorezos ES. The cancer is over, now what?: Understanding risk, changing outcomes. Cancer117(Suppl. 10), 2250–2257 (2011).
   Google Scholar
• Chemaitilly W, Sklar CA. Endocrine complications in long-term survivors of childhood cancers. Endocr. Relat. Cancer17(3), R141–R159 (2010).
   PubMed Web of Science ®Google Scholar
• Benesch M, Lackner H, Sovinz P et al. Late sequela after treatment of childhood low-grade gliomas: a retrospective analysis of 69 long-term survivors treated between 1983 and 2003. J. Neurooncol.78(2), 199–205 (2006).
   Google Scholar
• Mulder RL, Kremer LCM, Santen HMV et al. Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review. Cancer Treat. Rev.35(7), 616–632 (2009).
   PubMed Web of Science ®Google Scholar
• Appelman-Dijkstra NM, Kokshoorn NE, Dekkers OM et al. Pituitary dysfunction in adult patients after cranial radiotherapy: systematic review and meta-analysis. J. Clin. Endocrinol. Metab.96(8), 2330–2340 (2011).
   PubMed Web of Science ®Google Scholar
• Fernandez A, Brada M, Zabuliene L, Karavitaki N, Wass JA. Radiation-induced hypopituitarism. Endocr. Relat. Cancer16(3), 733–772 (2009).
   PubMed Web of Science ®Google Scholar
• Wachter D, Gondermann N, Oertel MF, Nestler U, Rohde V, Boker DK. Pituitary insufficiency after operation of supratentorial intra- and extra-axial tumors outside of the sellar–parasellar region? Neurosurg. Rev.34(4), 509–516 (2011).
   Google Scholar
• Arafah BM. Medical management of hypopituitarism in patients with pituitary adenomas. Pituitary5, 109–117 (2002).
   PubMedGoogle Scholar
• Schoenfeld GO, Amdur RJ, Schmalfuss IM et al. Low-dose prophylactic craniospinal radiotherapy for intracranial germinoma. Int. J. Radiat. Oncol. Biol. Phys.65(2), 481–485 (2006).
   PubMed Web of Science ®Google Scholar
• De Marinis L, Fusco A, Bianchi A et al. Hypopituitarism findings in patients with primary brain tumors 1 year after neurosurgical treatment: preliminary report. J. Endocrinol. Invest.29(6), 516–522 (2006).
   Google Scholar
• Gonzalez B, Vargas G, Espinosa-De-Los-Monteros AL, Sosa E, Mercado M. Efficacy and safety of radiotherapy in acromegaly. Arch. Med. Res.42(1), 48–52 (2011).
   PubMed Web of Science ®Google Scholar
• Merchant TE, Williams T, Smith JM et al. Preirradiation endocrinopathies in pediatric brain tumor patients determined by dynamic tests of endocrine function. Int. J. Radiat. Oncol. Biol. Phys.54(1), 45–50 (2002).
   PubMed Web of Science ®Google Scholar
• Schmiegelow M. Endocrinological late effects following radiotherapy and chemotherapy of childhood brain tumours. Dan. Med. Bull.53, 326–341 (2006).
   Google Scholar
• Borson-Chazot F, Brue T. Pituitary deficiency after brain radiation therapy. Ann. Endocrinol. (Paris)67(4), 303–309 (2006).
   PubMed Web of Science ®Google Scholar
• Di Mambro A, Giuliani C, Ammannati F et al. A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters. J. Endocrinol. Invest.33(7), 455–460 (2010).
   Google Scholar
• Dropcho EJ. Central nervous system injury by therapeutic irradiation. Neurol. Clin.9(4), 969–988 (1991).
   PubMed Web of Science ®Google Scholar
• Clark AJ, Chahal P, Mashiter K, Joplin GF. Lack of rise in serum prolactin following yttrium-90 interstitial irradiation for acromegaly. Clin. Endocrinol. (Oxf.)19(5), 557–563 (1983).
   Google Scholar
• Chieng PU, Huang TS, Chang CC, Chong PN, Tien RD, Su CT. Reduced hypothalamic blood flow after radiation treatment of nasopharyngeal cancer: SPECT studies in 34 patients. AJNR Am. J. Neuroradiol.12(4), 661–665 (1991).
   Google Scholar
• Roth C, Lakomek M, Schmidberger H, Jarry H. Cranial irradiation induces premature activation of the gonadotropin-releasing-hormone. Klin. Padiatr.213(4), 239–243 (2001).
   PubMedGoogle Scholar
• Nishioka H, Hirano A, Haraoka J, Nakajima N. Histological changes in the pituitary gland and adenomas following radiotherapy. Neuropathology22(1), 19–25 (2002).
   PubMed Web of Science ®Google Scholar
• Feigl GC, Pistracher K, Berghold A, Mokry M. Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas: the role of the hypothalamus. J. Neurosurg.113(Special Suppl.), 153–159 (2010).
   Google Scholar
• Degerblad M, Brismar K, Rahn T, Thoren M. The hypothalamus–pituitary function after pituitary stereotactic radiosurgery: evaluation of growth hormone deficiency. J. Intern. Med.253(4), 454–462 (2003).
   PubMed Web of Science ®Google Scholar
• Fajardo LF. Ionizing radiation and the endothelium. In: CURED I-LENT Late Effects of Cancer Treatment on Normal Tissues. Rubin P CLS, Marks LB, Okunieff P (Eds). Springer, Berlin, Germany, 19–22 (2008).
   Google Scholar
• Schaeffer M, Hodson DJ, Lafont C, Mollard P. Endocrine cells and blood vessels work in tandem to generate hormone pulses. J. Mol. Endocrinol.47(2), R59–R66 (2011).
   Google Scholar
• Darzy KH, Pezzoli SS, Thorner MO, Shalet SM. Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal. J. Clin. Endocrinol. Metab.92(5), 1666–1672 (2007).
   Google Scholar
• Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E, Shalet SM. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J. Clin. Endocrinol. Metab.88(1), 95–102 (2003).
   PubMed Web of Science ®Google Scholar
• Paulino AC, Jhaveri P, Dreyer Z, Teh BS, Okcu MF. Height impairment after lower dose cranial irradiation in children with acute lymphoblastic leukemia. Pediatric Blood Cancer56(2), 279–281 (2011).
   Google Scholar
• Clayton PE, Shalet SM. Dose dependency of time of onset of radiation-induced growth hormone deficiency. J. Pediatr.118(2), 226–228 (1991).
   PubMed Web of Science ®Google Scholar
• Constine LS, Woolf PD, Cann D et al. Hypothalamic–pituitary dysfunction after radiation for brain tumors. N. Engl. J. Med.328(2), 87–94 (1993).
   PubMed Web of Science ®Google Scholar
• Lam KS, Tse VK, Wang C, Yeung RT, Ho JH. Effects of cranial irradiation on hypothalamic-pituitary function – a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Q. J. Med.78(286), 165–176 (1991).
   PubMedGoogle Scholar
• Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q. J. Med.70(262), 145–160 (1989).
   PubMedGoogle Scholar
• Merchant TE, Conklin HM, Wu S, Lustig RH, Xiong X. Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. J. Clin. Oncol.27(22), 3691–3697 (2009).
   PubMed Web of Science ®Google Scholar
• Cheuk DK, Billups CA, Martin MG et al. Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma. Cancer117(1), 197–206 (2011).
   Google Scholar
• Agha A, Sherlock M, Brennan S et al. Hypothalamic–pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J. Clin. Endocrinol. Metab.90(12), 6355–6360 (2005).
   PubMed Web of Science ®Google Scholar
• Snyers A, Janssens GO, Twickler MB et al. Malignant tumors of the nasal cavity and paranasal sinuses: long-term outcome and morbidity with emphasis on hypothalamic-pituitary deficiency. Int. J. Radiat. Oncol. Biol. Phys.73(5), 1343–1351 (2009).
   PubMed Web of Science ®Google Scholar
• Sara M, Claudio F, Marco L et al. Time course of hypothalamic–pituitary deficiency in adults receiving cranial radiotherapy for primary extrasellar brain tumors. Radiother. Oncol.99(1), 23–28 (2011).
   Google Scholar
• Littley MD, Shalet SM, Beardwell CG, Robinson EL, Sutton ML. Radiation-induced hypopituitarism is dose-dependent. Clin. Endocrinol. (Oxf.)31(3), 363–373 (1989).
   PubMed Web of Science ®Google Scholar
• Linsenmeier C, Thoennessen D, Negretti L et al. Total body irradiation (TBI) in pediatric patients. Strahlenther. Onkol.186(11), 614–620 (2010).
   Google Scholar
• Castinetti F, Nagai M, Morange I et al. Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J. Clin. Endocrinol. Metab.94(9), 3400–3407 (2009).
   PubMed Web of Science ®Google Scholar
• Pai HH, Thornton A, Katznelson L et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose–effect relationship using dose–volume histogram analysis. Int. J. Radiat. Oncol. Biol. Phys.49(4), 1079–1092 (2001).
   PubMed Web of Science ®Google Scholar
• Marek J, Jezkova J, Hana V et al. Is it possible to avoid hypopituitarism after irradiation of pituitary adenomas by the Leksell Gamma Knife? Eur. J. Endocrinol.164(2), 169–178 (2011).
   Google Scholar
• Castinetti F, Regis J, Dufour H, Brue T. Role of stereotactic radiosurgery in the management of pituitary adenomas. Nat. Rev. Endocrinol.6(4), 214–223 (2010).
   PubMed Web of Science ®Google Scholar
• Feigl GC, Pistracher K, Berghold A, Mokry M. Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas: the role of the hypothalamus. J. Neurosurg.113(Suppl.), 153–159 (2010).
   Google Scholar
• Pollock BE, Cochran J, Natt N et al. Gamma Knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int. J. Radiat. Oncol. Biol. Phys.70(5), 1325–1329 (2008).
   PubMed Web of Science ®Google Scholar
• Felicetti F, Manicone R, Corrias A et al. Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution. J. Cancer Res. Clin. Oncol.137(9), 1343–1348 (2011).
   Google Scholar
• Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM. Growth hormone (GH) secretion and response to GH therapy after total body irradiation and haematopoietic stem cell transplantation during childhood. Clin. Endocrinol. (Oxf.)67(4), 589–597 (2007).
   Google Scholar
• Ogilvy-Stuart AL, Shalet SM. Effect of chemotherapy on growth. Acta Paediatr. Suppl.411, 52–56 (1995).
   Google Scholar
• Olshan JS, Gubernick J, Packer RJ et al. The effects of adjuvant chemotherapy on growth in children with medulloblastoma. Cancer70(7), 2013–2017 (1992).
   PubMed Web of Science ®Google Scholar
• Bakker B, Oostdijk W, Bresters D, Walenkamp MJ, Vossen JM, Wit JM. Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood. Bone Marrow Transplant.33(10), 1049–1056 (2004).
   Google Scholar
• Rose SR, Schreiber RE, Kearney NS et al. Hypothalamic dysfunction after chemotherapy. J. Pediatr. Endocrinol. Metab.17(1), 55–66 (2004).
   PubMed Web of Science ®Google Scholar
• Haddy TB, Mosher RB, Nunez SB, Reaman GH. Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation. Pediatric Blood Cancer46(2), 258–261 (2006).
   PubMed Web of Science ®Google Scholar
• Constine LS, Rubin P, Woolf PD, Doane K, Lush CM. Hyperprolactinemia and hypothyroidism following cytotoxic therapy for central nervous system malignancies. J. Clin. Oncol.5(11), 1841–1851 (1987).
   PubMedGoogle Scholar
• Van Santen HM. No damaging effect of chemotherapy in addition to radiotherapy on the thyroid axis in young adult survivors of childhood cancer. J. Clin. Endocrinol. Metabol.88(8), 3657–3663 (2003).
   PubMedGoogle Scholar
• Bilgir O, Kebapcilar L, Bilgir F et al. Is there any relationship between imatinib mesylate medication and hypothalamic–pituitary–adrenal axis dysfunction? Int. J. Clin. Pract.64(1), 45–50 (2010).
   PubMed Web of Science ®Google Scholar
• Kebapcilar L, Bilgir O, Alacacioglu I et al. Does imatinib mesylate therapy cause growth hormone deficiency? Med. Princ. Pract.18(5), 360–363 (2009).
   PubMed Web of Science ®Google Scholar
• Sukumari-Ramesh S, Singh N, Dhandapani KM, Vender JR. mTOR inhibition reduces cellular proliferation and sensitizes pituitary adenoma cells to ionizing radiation. Surg. Neurol. Int.2, 22 (2011).
   Google Scholar
• Dillard T, Yedinak CG, Alumkal J, Fleseriu M. Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune-related adverse events across a spectrum of cancer subtypes. Pituitary13(1), 29–38 (2010).
   PubMed Web of Science ®Google Scholar
• Beltran SRM, Berlier P, Sunyach MP, Borson-Chazot F, Frappaz D. Endocrine function after craniospinal irradiation for medulloblastoma in children and adults. Neuro. Oncol.11(5), 659 (2009).
   Google Scholar
• Shalitin S, Gal M, Goshen Y, Cohen I, Yaniv I, Phillip M. Endocrine outcome in long-term survivors of childhood brain tumors. Hormone Res. Paediatrics76(2), 113–122 (2011).
   Google Scholar
• Lam KS, Ho JH, Lee AW et al. Symptomatic hypothalamic–pituitary dysfunction in nasopharyngeal carcinoma patients following radiation therapy: a retrospective study. Int. J. Radiat. Oncol. Biol. Phys.13(9), 1343–1350 (1987).
   Google Scholar
• Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendenhall WM. Hypopituitarism after radiotherapy for extracranial head and neck cancers. Head Neck30(9), 1182–1192 (2008).
   Google Scholar
• Ayuk J, Stewart PM. Mortality following pituitary radiotherapy. Pituitary12(1), 35–39 (2009).
   Google Scholar
• Bercu BB, Diamond FB Jr. Growth hormone neurosecretory dysfunction. Clin. Endocrinol. Metab.15(3), 537–590 (1986).
   Google Scholar
• Laughton SJ, Merchant TE, Sklar CA et al. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J. Clin. Oncol.26(7), 1112–1118 (2008).
   PubMed Web of Science ®Google Scholar
• Diller L, Chow EJ, Gurney JG et al. Chronic disease in the childhood cancer survivor study cohort: a review of published findings. J. Clin. Oncol.27(14), 2339–2355 (2009).
   PubMed Web of Science ®Google Scholar
• Jarfelt M, Bjarnason R, Lannering B. Young adult survivors of childhood acute lymphoblastic leukemia: spontaneous GH secretion in relation to CNS radiation. Pediatric Blood Cancer42(7), 582–588 (2004).
   Google Scholar
• Verhelst J, Mattsson AF, Luger A et al. Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. Eur. J. Endocrinol.165(6), 881–889 (2011).
   Google Scholar
• Darzy KH, Shalet SM. Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement. Growth Horm IGF Res.16(Suppl. A), S30–S40 (2006).
   Google Scholar
• Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M. Consensus statement on the management of the GH-treated adolescent in the transition to adult care. Eur. J. Endocrinol.152(2), 165–170 (2005).
   PubMed Web of Science ®Google Scholar
• Murray RD, Adams JE, Smethurst LE, Shalet SM. Spinal irradiation impairs the osteo-anabolic effects of low-dose GH replacement in adults with childhood-onset GH deficiency. Clin. Endocrinol. (Oxf.)56(2), 169–174 (2002).
   Google Scholar
• Armstrong GT, Liu Q, Yasui Y et al. Late mortality among 5-year survivors of childhood cancer: a summary from the childhood cancer survivor study. J. Clin. Oncol.27(14), 2328–2338 (2009).
   PubMed Web of Science ®Google Scholar
• Ergun-Longmire B, Mertens AC, Mitby P et al. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J. Clin. Endocrinol. Metab.91(9), 3494–3498 (2006).
   PubMed Web of Science ®Google Scholar
• Blethen SL, Rundle AC. Slipped capital femoral epiphysis in children treated with growth hormone. A summary of the National Cooperative Growth Study experience. Hormone Res.46(3), 113–116 (1996).
   PubMed Web of Science ®Google Scholar
• Clemmons DR. The diagnosis and treatment of growth hormone deficiency in adults. Curr. Opin. Endocrinol. Diabetes Obes.17(4), 377–383 (2010).
   Google Scholar
• Green DM, Kawashima T, Stovall M et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J. Clin. Oncol.27(16), 2677–2685 (2009).
   PubMed Web of Science ®Google Scholar
• Bath LE, Anderson RA, Critchley HO, Kelnar CJ, Wallace WH. Hypothalamic–pituitary–ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Human Reproduct. (Oxf. Engl.)16(9), 1838–1844 (2001).
   PubMed Web of Science ®Google Scholar
• Gross KM, Matsumoto AM, Southworth MB, Bremner WJ. Evidence for decreased luteinizing hormone-releasing hormone pulse frequency in men with selective elevations of follicle-stimulating hormone. J. Clin. Endocrinol. Metab.60(1), 197–202 (1985).
   Google Scholar
• Wildt L, Hausler A, Marshall G et al. Frequency and amplitude of gonadotropin-releasing hormone stimulation and gonadotropin secretion in the rhesus monkey. Endocrinology109(2), 376–385 (1981).
   PubMed Web of Science ®Google Scholar
• Laporte S, Couto-Silva AC, Trabado S et al. Inhibin B and anti-Müllerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood. BMC Pediatr.11, 20 (2011).
   Google Scholar
• Livesey EA, Hindmarsh PC, Brook CG et al. Endocrine disorders following treatment of childhood brain tumours. Br. J. Cancer61(4), 622–625 (1990).
   PubMed Web of Science ®Google Scholar
• Littley MD, Shalet SM, Morgenstern GR, Deakin DP. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Q. J. Med.78(287), 265–274 (1991).
   PubMedGoogle Scholar
• Ogilvy-Stuart AL, Clark DJ, Wallace WH et al. Endocrine deficit after fractionated total body irradiation. Arch. Dis. Childhood67(9), 1107–1110 (1992).
   PubMed Web of Science ®Google Scholar
• Schneider HJ, Rovere S, Corneli G et al. Endocrine dysfunction in patients operated on for nonpituitary intracranial tumors. Eur. J. Endocrinol.155(4), 559–566 (2006).
   Google Scholar
• Pai HH, Thornton A, Katznelson L et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose–effect relationship using dose–volume histogram analysis. Int. J. Radiat. Oncol. Biol. Phys.49(4), 1079–1092 (2001).
   PubMed Web of Science ®Google Scholar
• Bhandare N, Kennedy L, Malyapa RS, Morris CG, Mendenhall WM. Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int. J. Radiat. Oncol. Biol. Phys.68(4), 1131–1139 (2007).
   Google Scholar
• Darzy KH. Radiation-induced hypopituitarism after cancer therapy: who, how and when to test. Nat. Clin. Pract. Endocrinol. Metab.5(2), 88–99 (2009).
   PubMedGoogle Scholar
• Carter JN, Tyson JE, Tolis G, Van Vliet S, Faiman C, Friesen HG. Prolactin-screening tumors and hypogonadism in 22 men. N. Engl. J. Med.299(16), 847–852 (1978).
   PubMed Web of Science ®Google Scholar
• Sham J, Choy D, Kwong PW et al. Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio. Int. J. Radiat. Oncol. Biol. Phys.29(4), 699–704 (1994).
   PubMedGoogle Scholar
• Coons JM, Moreman C, Ragains M, Scalf K, Vitaz T, Spalding A. Improvement of therapeutic index for brain tumors with daily image guidance. Int. J. Radiat. Oncol. Biol. Phys.78(3), S277–S278 (2010).
   Google Scholar
• Alapetite C, Puget S, Bolle S et al. Protontherapy for craniopharyngioma in children: the Orsay proton center experience. Pediat. Blood Cancer55(5), 791–792 (2010).
   Google Scholar
• Minniti G, Clarke E, Cavallo L et al. Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas. Radiation Oncol.6, 36 (2011).
   PubMed Web of Science ®Google Scholar
• Shih HA, Arvold ND, Niemierko A, Broussard GP, Fullerton B, Loeffler JS. Second tumor risk and projected late effects after proton vs intensity modulated photon radiotherapy for benign meningioma: a dosimetric comparison. Int. J. Radiat. Oncol. Biol. Phys.78(3), S272 (2010).
   Google Scholar
• Minniti G, Gilbert DC, Brada M. Modern techniques for pituitary radiotherapy. Rev. Endocr. Metab. Disord.10(2), 135–144 (2009).
   PubMed Web of Science ®Google Scholar
• Udalova N, Strebkova N, Kuznetsova E, Peterkova V. Long-term anterior pituitary function in a cohort of pediatric Cushing’s disease after proton therapy. Hormone Res. Paediatr.76(Suppl. 2), 49–118 (2011).
   Google Scholar
• Iwata H, Sato K, Tatewaki K et al. Hypofractionated stereotactic radiotherapy with CyberKnife for nonfunctioning pituitary adenoma: high local control with low toxicity. Neuro. Oncol.13(8), 916–922 (2011).
   Google Scholar
• Taussky P, Kalra R, Coppens J, Mohebali J, Jensen R, Couldwell WT. Endocrinological outcome after pituitary transposition (hypophysopexy) and adjuvant radiotherapy for tumors involving the cavernous sinus. J. Neurosurg.115(1), 55–62 (2011).
   Google Scholar
• Onal C, Kayaselcuk F, Topkan E, Yavuz M, Bacanli D, Yavuz A. Protective effects of melatonin and octreotide against radiation-induced intestinal injury. Digest. Dis. Sci.56(2), 359–367 (2011).
   PubMed Web of Science ®Google Scholar
• Landolt AM, Haller D, Lomax N et al. Octreotide may act as a radioprotective agent in acromegaly. J. Clin. Endocrinol. Metab.85(3), 1287–1289 (2000).
   PubMed Web of Science ®Google Scholar
• Del Mastro L, Boni L, Michelotti A et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA306(3), 269–276 (2011).
   PubMed Web of Science ®Google Scholar
• Minniti G, Saran F, Traish D et al. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Radiother. Oncol.82(1), 90–95 (2007).
   PubMed Web of Science ®Google Scholar
• Rubin P, Constine LS, Fajardo LF, Phillips TL, Wasserman TH. Overview of late effects normal tissues (LENT) scoring system. Radiother. Oncol.35(1), 9–10 (1995).
   PubMedGoogle Scholar
• Pavy JJ, Denekamp J, Letschert J et al. Late effects toxicity scoring: the SOMA scale. Radiother. Oncol.35(1), 11–15 (1995).
   PubMed Web of Science ®Google Scholar
• No authors listed. LENT SOMA tables. Radiother. Oncol.35(1), 17–60 (1995).
   PubMed Web of Science ®Google Scholar
• Johannesen TB, Hole KH, Rasmussen K et al. Late radiation injury of the central nervous system, recording of morbidity according to the SOMA/LENT scoring system. Int. J. Radiat. Oncol. Biol. Phys.51(3), 251–252 (2001).
   Google Scholar
• Nandagopal R, Laverdiere C, Mulrooney D, Hudson MM, Meacham L. Endocrine late effects of childhood cancer therapy: a report from the Children’s Oncology Group. Hormone Res.69(2), 65–74 (2008).
   PubMedGoogle Scholar
• Langsenlehner T, Stiegler C, Quehenberger F et al. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome. Strahlenther. Onkol.183(5), 241–247 (2007).
   Google Scholar